Based on your #2, would be keen to know what effect compliance listing will have. Is it a positive one or negative? Any pharma companies in recent times that have listed this way? Less interest and action on the SP upon listing?
IHL New Strategy, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)